Quantinuum (NASDAQ:QNT) Price Target Cut to $60.00 by Analysts at Needham & Company LLC

Key Points

• Needham cut its Quantinuum price target to $60 from $100 but maintained a Buy rating; the new target implies 101.21% upside from the prior close.
• Analyst opinion remains broadly favorable: MarketBeat reports a Moderate Buy consensus and an average price target of $88.46, though Cantor Fitzgerald also lowered its target, to $55.
• Quantinuum reported a quarterly loss of $0.29 per share, narrower than analysts’ expected $0.99 loss, on revenue of $9.05 million; the stock opened at $29.82 on Friday.

Quantinuum (NASDAQ:QNT - Get Free Report) had its price objective dropped by stock analysts at Needham & Company LLC from $100.00 to $60.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has a "buy" rating on the stock. Needham & Company LLC's price target points to a potential upside of 101.21% from the company's previous close.

Several other equities research analysts have also recently weighed in on the stock. Sanford C. Bernstein reiterated a "hold" rating on shares of Quantinuum in a research report on Wednesday, August 12th. Jefferies Financial Group set a $85.00 target price on shares of Quantinuum in a report on Wednesday, August 12th. Yorkville Ives started coverage on shares of Quantinuum in a research report on Monday, October 5th. They set an "outperform" rating and a $60.00 price target on the stock. Cantor Fitzgerald decreased their price target on Quantinuum from $90.00 to $55.00 and set an "overweight" rating for the company in a report on Friday. Finally, Weiss Ratings started coverage on Quantinuum in a report on Monday, August 31st. They set a "sell (d)" rating for the company. Thirteen research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $88.46.

Quantinuum Price Performance

NASDAQ:QNT opened at $29.82 on Friday. The firm has a market cap of $7.85 billion and a P/E ratio of -106.50. The firm's 50 day moving average price is $43.74. Quantinuum has a fifty-two week low of $28.31 and a fifty-two week high of $86.79.

Quantinuum (NASDAQ:QNT - Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.99) by $0.70. The firm had revenue of $9.05 million for the quarter. As a group, research analysts expect that Quantinuum will post -4.76 EPS for the current fiscal year.

Hedge Funds Weigh In On Quantinuum

Institutional investors and hedge funds have recently modified their holdings of the business. CoreCap Advisors LLC acquired a new stake in Quantinuum in the third quarter worth $32,000. Fifth Third Bancorp increased its stake in Quantinuum by 1,530.2% in the third quarter. Fifth Third Bancorp now owns 1,027 shares of the company's stock valued at $49,000 after purchasing an additional 964 shares in the last quarter. IFP Advisors Inc raised its holdings in shares of Quantinuum by 1,150.0% during the third quarter. IFP Advisors Inc now owns 1,250 shares of the company's stock valued at $60,000 after purchasing an additional 1,150 shares during the period. Pier 88 Investment Partners LLC acquired a new position in shares of Quantinuum during the third quarter valued at about $154,000. Finally, Flagship Harbor Advisors LLC bought a new position in shares of Quantinuum during the 3rd quarter worth about $206,000.

Key Headlines Impacting Quantinuum

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Raised revenue outlook and strong growth: Third-quarter revenue increased 233% year over year, and Quantinuum raised its FY2026 revenue outlook. It also reported a loss of $0.29 per share, narrower than the $0.99 loss analysts expected. Quantinuum Q3 results and outlook
• Positive Sentiment: Improving commercial traction: The company said platform adoption rose nearly 20% quarter over quarter, job submissions increased tenfold year over year, and it secured its largest cloud agreement to date, alongside a hyperscaler agreement and an Oracle beta launch. Quantinuum Q3 results and outlook
• Positive Sentiment: Broker sentiment is favorable: Wall Street brokerages collectively rate QNT “Moderate Buy,” which may support investor confidence. Quantinuum analyst rating
• Neutral Sentiment: Long-term technology roadmap: Quantinuum outlined Nexus, a developer platform intended to connect application development with its hardware, including the Apollo fault-tolerant system planned for 2029. The roadmap offers potential but depends on future execution. Nexus roadmap announcement
• Negative Sentiment: Losses persist: Despite beating the quarterly EPS estimate, QNT remained unprofitable, reporting a $0.29-per-share loss. Continued losses could weigh on investor sentiment as the company works to scale its business. Quantinuum quarterly earnings report

Quantinuum Company Profile

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum's software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.